← Back to Search

Procedure

EPR for Traumatic Cardiac Arrest (EPR-CAT Trial)

Phase 2
Waitlist Available
Led By Samuel A Tisherman, MD
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new method of saving people who have suffered cardiac arrest from bleeding.

Eligible Conditions
  • Heart Attack

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Emergency preservation and resuscitationExperimental Treatment1 Intervention
These subjects would undergo the complete EPR protocol, including rapid induction of hypothermia, resuscitative surgery, and resuscitation with cardiopulmonary bypass.
Group II: Concurrent controlsActive Control1 Intervention
These subjects would undergo standard resuscitative efforts.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
713 Previous Clinical Trials
379,472 Total Patients Enrolled
Cook County HealthOTHER_GOV
46 Previous Clinical Trials
16,817 Total Patients Enrolled
John H. Stroger HospitalOTHER
42 Previous Clinical Trials
13,035 Total Patients Enrolled

Media Library

Emergency preservation and resuscitation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT01042015 — Phase 2
Heart Attack Research Study Groups: Concurrent controls, Emergency preservation and resuscitation
Heart Attack Clinical Trial 2023: Emergency preservation and resuscitation Highlights & Side Effects. Trial Name: NCT01042015 — Phase 2
Emergency preservation and resuscitation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01042015 — Phase 2
~2 spots leftby Nov 2025